Home / Pharmaceutical company intelligence
Geofman Pharmaceuticals logo
Pharmaceutical company intelligence

Geofman Pharmaceuticals

Pharmaceutical manufacturer · Karachi · Pakistan

Karachi pharmaceutical manufacturer with a long operating history and a broad portfolio across major therapeutic categories.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation22 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date23 Jul 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Pharmaceutical manufacturer
Address
107/23, Korangi Industrial Area, Karachi, Pakistan
Phone
+92 370 0225246
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000090 92 linked products · source seen 22 Sep 2026 View source ↗
Corporate profile source ledger Logo Url source ↗ Contact Page Url source ↗ Logo Source Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx92public portfolio records represented
REG77unique registrations represented
IDX92indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR85current validated price records
G47generic molecules in indexed catalogue
DF9dosage-form groups
TA14therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage92%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage95%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixGeofman PharmaceuticalsShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/geofman-pharmaceuticalsGenerated 23 Sep 2026Anti-infectives47 · 51%Fluids & supportive care8 · 9%Dermatology6 · 7%Respiratory & allergy5 · 5%Cross-therapeutic & anti-inflamma…4 · 4%Reproductive & genitourinary4 · 4%Pain & musculoskeletal4 · 4%Other therapeutic areas14 · 15%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioGeofman PharmaceuticalsDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/geofman-pharmaceuticalsGenerated 23 Sep 202692presentationsTablet30 · 33%Injection29 · 32%Suspension10 · 11%Capsule8 · 9%Cream5 · 5%Infusion4 · 4%Other forms6 · 7%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionGeofman PharmaceuticalsCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/geofman-pharmaceuticalsGenerated 23 Sep 202687comparable productsBelow peer median20 · 23%Near peer median33 · 38%Above peer median34 · 39%Company median price position+0.0%Lowest-price equivalents9Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsGeofman PharmaceuticalsCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/geofman-pharmaceuticalsGenerated 23 Sep 2026Zafa Pharmaceutical Laboratories (P…29 shared62% overlapMediate Pharmaceutical Pvt Ltd27 shared57% overlapBosch Pharmaceuticals (Pvt) Ltd.25 shared53% overlapPharmasol (Pvt) Ltd.24 shared51% overlapNeutro Pharma (Pvt.) Ltd.,24 shared51% overlapS.J & G. Fazul Ellahie (pvt) limite…24 shared51% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives47 products · 51%
Fluids & supportive care8 products · 9%
Dermatology6 products · 7%
Respiratory & allergy5 products · 5%
Cross-therapeutic & anti-inflammatory4 products · 4%
Reproductive & genitourinary4 products · 4%
Pain & musculoskeletal4 products · 4%
Cardiovascular3 products · 3%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Third-generation cephalosporins14 products · 15%
Fluids, electrolytes & diluents8 products · 9%
Topical corticosteroids / anti-inflammatory dermatologics6 products · 7%
Fluoroquinolone antibacterials5 products · 5%
Penicillin antibacterials5 products · 5%
Systemic corticosteroids4 products · 4%
Aminoglycoside antibacterials4 products · 4%
Macrolide antibacterials4 products · 4%
Formulation footprint

Dosage forms

Tablet30 products
Injection29 products
Suspension10 products
Capsule8 products
Cream5 products
Infusion4 products
Ointment3 products
Solution2 products
Pessary1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 TY-OXONECeftriaxone 6presentations 1 g, 250 mg, 500 mg · Injection #2 BETACINBetamethasone 5presentations 0.1 %, 0.1% · Cream, Ointment #3 GEOMOXINAmoxicillin 5presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL, 500 mg · Suspension, Capsule #4 DERMOTRIMClotrimazole 3presentations 1 %, 500 mg · Cream, Pessary #5 ELECTROSOL KCLPotassium chloride 3presentations 7.46 % · Injection #6 GEOKACINAmikacin 3presentations 100 mg, 250 mg, 500 mg · Injection
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median2023% of comparable products
Near market median33within ±5% of median
Above market median3439% of comparable products
Lowest-price equivalents9ties included
Company median price position +0.0% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
TESTOSTERONE 250 mg/mLTestosterone · Injection · 3 x 1ml PKR 7.76/mL-94.3% vs market median Water for Injection 5 mLWater for Injection · Injection · 100 x 5ml PKR 0.14/mL-93.1% vs market median Water for Injection 10 mLWater for Injection · Injection · 100 x 10ml PKR 0.49/mL-76.8% vs market median LIFESOL 5% 5 %Dextrose · IV infusion · 500ml PKR 0.15/mL-65.4% vs market median CIFAZ 1 gCefazolin · Injection · 1's PKR 93.19/vial/unit-55.9% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Zafa Pharmaceutical Laboratories (Pvt) Ltd.245 products · 97 generics 29shared generics Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 27shared generics Bosch Pharmaceuticals (Pvt) Ltd.258 products · 74 generics 25shared generics Pharmasol (Pvt) Ltd.257 products · 102 generics 24shared generics Neutro Pharma (Pvt.) Ltd.,210 products · 97 generics 24shared generics S.J & G. Fazul Ellahie (pvt) limited.193 products · 68 generics 24shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers77Distinct registrations among indexed, published, presentation-validated products only
Verified price observations92
Products with a verified price92
Products with multiple price observations0
Source records with multiple versions92
Latest portfolio source check22 Sep 2026
Latest effective price date23 Jul 2026
Latest source observation22 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

77 unique registration(s) · 92 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
ATOPITAR Atorvastatin 20 mg Tablet 10's 042005 PKR 710.59 PKR 71.06/tablet 52% above median
ATOPITAR Atorvastatin 40 mg Tablet 10's 042006 PKR 990.19 PKR 99.02/tablet 32% above median
BETACIN Betamethasone 0.1 % Cream 5gm 009316 PKR 26.79 PKR 5.36/g 17% above median
BETACIN Betamethasone 0.1 % Cream 10gm 009316 PKR 52.42 PKR 5.24/g 15% above median
BETACIN Betamethasone 0.1 % Cream 15gm 009316 PKR 68.42 PKR 4.56/g 9% below median
BETACIN Betamethasone 0.1% Ointment 15gm 009317 PKR 56.41 PKR 3.76/g 24% below median
BETACIN Betamethasone 0.1 % Ointment 5gm 009317 PKR 26.79 PKR 5.36/g 25% above median
BETACIN Ointment Betamethasone 0.1 % Ointment 10gm 009317 PKR 52.42 PKR 5.24/g 22% above median
Biotran Forte Trimethoprim 160 mg Tablet 100's 005414 PKR 502.37 PKR 5.02/tablet No comparator
BISACODYL Bisacodyl 5 mg Tablet 100's 004957 PKR 38.73 PKR 0.39/tablet 31% below median
CAPSIDON Doxycycline 100 mg Capsule 1's 008963 PKR 10.72 PKR 10.72/capsule 37% above median
CEFOXIM Cefotaxime 500 mg Injection Vial 022087 PKR 158.95 PKR 158.95/vial/unit Near median
CEFOXIM Cefotaxime 1 g Injection Vial 022088 PKR 285.88 PKR 285.88/vial/unit Near median
CIFAZ Cefazolin 1 g Injection 1's 061549 PKR 93.19 PKR 93.19/vial/unit 56% below median
DERMOTRIM Clotrimazole 1 % Cream 20gm 022090 PKR 203.65 PKR 10.18/g 64% above median
DERMOTRIM Clotrimazole 1 % Cream 10gm 022090 PKR 95.13 PKR 9.51/g 54% above median
DERMOTRIM Clotrimazole 500 mg Vaginal tablet 1's 022091 PKR 152.64 PKR 152.64/tablet 20% above median
DEXAMEDRON Dexamethasone 4 mg/mL Injection 1ml x 25's 010004 PKR 461.95 PKR 18.48/mL Near median
DEXAMETHASONE Dexamethasone 0.5 mg Tablet 1000's 005238 PKR 646.23 PKR 0.65/tablet 21% above median
DEXAMETHASONE Dexamethasone 0.5 mg Tablet 100's 005238 PKR 104.64 PKR 1.05/tablet 96% above median
DIABIMIN Metformin 500 mg Tablet 5 x 10's 027617 PKR 164.15 PKR 3.28/tablet 22% above median
DIABIMIN Metformin 850 mg Tablet 5 x 10's 036213 PKR 120.08 PKR 2.40/tablet 45% below median
ELECTROSOL KCL Potassium chloride 7.46 % Injection 25ml x 50's 022092 PKR 726.65 PKR 0.58/mL Near median
ELECTROSOL KCL Potassium chloride 7.46 % Injection 20ml 022092 PKR 11.81 PKR 0.59/mL Near median
ELECTROSOL KCL Potassium chloride 7.46 % Injection 20ml x 50's 022092 PKR 590.68 PKR 0.59/mL Near median
FENTIN Phenytoin sodium 50 mg/mL Injection 5's x1ml 037007 PKR 485.38 PKR 97.08/mL 75% above median
FEXTIM Fluoxetine 20 mg Capsule 2 x 7's 027619 PKR 279.58 PKR 19.97/capsule 54% above median
Folic Acid Folic acid 5 mg Tablet 1000's 005821 PKR 402.00 PKR 0.40/tablet 50% below median
Folic Acid Folic acid 5 mg Tablet 10 x 10's 005821 PKR 115.09 PKR 1.15/tablet 44% above median
GENOM Gentamicin 80 mg Injection 10x2ml 018385 PKR 502.25 PKR 25.11/mL 82% above median
GEOERYTHCIN Erythromycin Stearate 250 mg Tablet 10x10's 014841 PKR 555.39 PKR 5.55/tablet 17% below median
GEOERYTHCIN Erythromycin 200 mg/5 mL Suspension 60ml 015396 PKR 71.70 PKR 1.20/mL 51% above median
GEOFLOX Ofloxacin 2 mg IV infusion 100ml 037377 PKR 194.15 PKR 1.94/mL No comparator
GEOGYNON Norethisterone 10 mg Tablet 2's 008992 PKR 12.52 PKR 6.26/tablet No comparator
GEOKACIN Amikacin 100 mg Injection 2ml 053413 PKR 79.60 PKR 39.80/mL 8% below median
GEOKACIN Amikacin 250 mg Injection 2ml 053414 PKR 128.15 PKR 64.08/mL Near median
GEOKACIN Amikacin 500 mg Injection 2ml 053415 PKR 242.69 PKR 121.35/mL Near median
GEOMOL Paracetamol 500 mg Tablet 20 x 10's 005627 PKR 762.93 PKR 3.81/tablet 5% above median
GEOMOL Paracetamol 500 mg Tablet 1000's 005627 PKR 3,662.05 PKR 3.66/tablet Near median
GEOMOXIN Amoxicillin 250 mg Capsule 12's 005672 PKR 135.50 PKR 11.29/capsule Near median
GEOMOXIN Amoxicillin 250 mg Capsule 100's 005672 PKR 1,129.16 PKR 11.29/capsule Near median
GEOMOXIN Amoxicillin 125 mg/5 mL Suspension 60ml 017613 PKR 91.49 PKR 1.52/mL Near median
GEOMOXIN Amoxicillin 250 mg/5 mL Suspension 60ml 017614 PKR 134.34 PKR 2.24/mL Near median
GEOMOXIN Amoxicillin 500 mg Capsule 100's 017615 PKR 1,995.43 PKR 19.95/capsule Near median
GEOPIDOGREL Clopidogrel 75 mg Tablet 10's 061771 PKR 271.80 PKR 27.18/tablet Near median
GEOZIT Azithromycin 250 mg Capsule 10's 035419 PKR 388.30 PKR 38.83/capsule 22% below median
GEOZIT Azithromycin 200 mg/5 mL Suspension 15ml 037136 PKR 320.35 PKR 21.36/mL Near median
GEOZOLE Mebendazole 100 mg Tablet 300's 018104 PKR 1,999.22 PKR 6.66/tablet Near median
GLABINOL Glibenclamide 5 mg Tablet 10 x 6's 018383 PKR 212.04 PKR 3.53/tablet 48% above median
IBUPROFEN Ibuprofen 400 mg Tablet 25 x 10's 009308 PKR 929.55 PKR 3.72/tablet 6% above median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Geofman Pharmaceuticals — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/company/geofman-pharmaceuticals/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.